| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledging our reviewers
|
|
|
|
5 |
1 |
p.
|
artikel
|
| 2 |
A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis
|
Harrison, Stephen A.
|
|
|
5 |
1 |
p.
|
artikel
|
| 3 |
Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis
|
Rim, Chai Hong
|
|
|
5 |
1 |
p.
|
artikel
|
| 4 |
Contents
|
|
|
|
5 |
1 |
p.
|
artikel
|
| 5 |
Copyright and information
|
|
|
|
5 |
1 |
p.
|
artikel
|
| 6 |
Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)
|
Marcellin, Fabienne
|
|
|
5 |
1 |
p.
|
artikel
|
| 7 |
Editorial Board page
|
|
|
|
5 |
1 |
p.
|
artikel
|
| 8 |
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
|
Scheiner, Bernhard
|
|
|
5 |
1 |
p.
|
artikel
|
| 9 |
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination
|
Codoni, Greta
|
|
|
5 |
1 |
p.
|
artikel
|
| 10 |
Liver steatosis induces portal hypertension regardless of fibrosis in patients with NAFLD: A proof of concept case report
|
Rivera-Esteban, Jesús
|
|
|
5 |
1 |
p.
|
artikel
|
| 11 |
Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis
|
Crudele, Lucilla
|
|
|
5 |
1 |
p.
|
artikel
|
| 12 |
Patient-reported outcomes in NAFLD/NASH clinical trials: A blind spot that needs addressing
|
Sena, Elena
|
|
|
5 |
1 |
p.
|
artikel
|
| 13 |
Physical activity is inversely associated with hepatic fibro-inflammation: A population-based cohort study using UK Biobank data
|
Sherry, Aron P.
|
|
|
5 |
1 |
p.
|
artikel
|
| 14 |
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
|
Lazarus, Jeffrey V.
|
|
|
5 |
1 |
p.
|
artikel
|
| 15 |
Sarcopenia-related gut microbial changes are associated with the risk of complications in people with cirrhosis
|
Lee, Pei-Chang
|
|
|
5 |
1 |
p.
|
artikel
|
| 16 |
SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression
|
Lei, Martina Mang Leng
|
|
|
5 |
1 |
p.
|
artikel
|
| 17 |
Serious adverse events after cessation of nucleos(t)ide analogues in individuals with chronic hepatitis B: A systematic review and meta-analysis
|
Tseng, Cheng-Hao
|
|
|
5 |
1 |
p.
|
artikel
|
| 18 |
Social support and risk of mortality in cirrhosis: A cohort study
|
Askgaard, Gro
|
|
|
5 |
1 |
p.
|
artikel
|
Tijdschrift beschrijving